Eagle Pharmaceuticals Inc (EGRX) — Net Asset Momentum
Eagle Pharmaceuticals Inc (EGRX) recorded a net asset momentum of 32.4% as of December 2022, with net assets of $233.56 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Eagle Pharmaceuticals Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Eagle Pharmaceuticals Inc Net Asset Momentum (2012–2022)
This chart tracks Eagle Pharmaceuticals Inc's year-over-year net asset growth across 11 annual reporting periods from 2012 to 2022. The most recent momentum reading is +32.4%, with net assets of $233.56 Million USD as of December 2022. Read EGRX current and long-term liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Eagle Pharmaceuticals Inc (2012–2022)
The table below shows the complete annual net asset history for Eagle Pharmaceuticals Inc from 2012 to 2022, covering 11 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see how much is Eagle Pharmaceuticals Inc worth.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2022 | $233.56 Million | $406.16 Million | $172.60 Million | ▲ +32.4% |
| 2021 | $176.45 Million | $253.73 Million | $77.28 Million | ▼ -5.1% |
| 2020 | $186.01 Million | $253.19 Million | $67.18 Million | ▲ +3.8% |
| 2019 | $179.17 Million | $254.55 Million | $75.38 Million | ▲ +11.5% |
| 2018 | $160.76 Million | $238.60 Million | $77.84 Million | ▼ -10.3% |
| 2017 | $179.14 Million | $270.06 Million | $90.92 Million | ▲ +18.5% |
| 2016 | $151.23 Million | $213.57 Million | $62.34 Million | ▲ +67.4% |
| 2015 | $90.34 Million | $124.61 Million | $34.26 Million | ▲ +173.0% |
| 2014 | $33.10 Million | $53.41 Million | $20.32 Million | ▲ +1511.3% |
| 2013 | $2.05 Million | $18.10 Million | $16.05 Million | ▲ +117.0% |
| 2012 | $-12.10 Million | $9.44 Million | $21.54 Million | — |